Shelton Wealth Management »

Halozyme Therapeutics shares owned by Shelton Wealth Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Shelton Wealth Management from 13F filings

Historical chart of Shelton Wealth Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Shelton Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Shelton Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 21k 67.30
2025-09-30 $1.5M 20k 73.34
2025-06-30 $843k 16k 52.02
2024-09-30 $997k 17k 57.24
2024-06-30 $918k 18k 52.36
2024-03-31 $734k 18k 40.68

More positions owned by Shelton Wealth Management

First Tr Exchange-traded First Tr Enh New (FTSM)
Ishares Tr Ibonds 29 Trm Ts (IBTJ)
Ishares Tr Ibond Dec 2030 (IBTK)
Ishares Tr Ibonds 28 Trm Ts (IBTI)
Ishares Tr Ibonds 27 Trm Ts (IBTH)
Ishares Tr Ibonds 26 Trm Ts (IBTG)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Rus 1000 Etf (IWB)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Applovin Corp Com Cl A Call Option (APP)
Ishares Msci Emrg Chn (EMXC)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Shelton Wealth Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics